- Home
- EVGN vs APCX Comparison
EVGN vs APCX Comparison
Compare EVGN & APCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGN
- APCX
- Stock Information
- Founded
- EVGN 1999
- APCX 2006
- Country
- EVGN Israel
- APCX United States
- Employees
- EVGN N/A
- APCX N/A
- Industry
- EVGN Agricultural Chemicals
- APCX Finance: Consumer Services
- Sector
- EVGN Industrials
- APCX Finance
- Exchange
- EVGN Nasdaq
- APCX Nasdaq
- Market Cap
- EVGN 9.7M
- APCX N/A
- IPO Year
- EVGN N/A
- APCX N/A
- Fundamental
- Price
- EVGN $1.35
- APCX $0.60
- Analyst Decision
- EVGN Strong Buy
- APCX
- Analyst Count
- EVGN 1
- APCX 0
- Target Price
- EVGN $12.00
- APCX N/A
- AVG Volume (30 Days)
- EVGN 58.6K
- APCX 10.6M
- Earning Date
- EVGN 11-21-2024
- APCX 11-14-2024
- Dividend Yield
- EVGN N/A
- APCX N/A
- EPS Growth
- EVGN N/A
- APCX N/A
- EPS
- EVGN N/A
- APCX N/A
- Revenue
- EVGN $7,478,000.00
- APCX $365,000.00
- Revenue This Year
- EVGN $90.35
- APCX $1,315.48
- Revenue Next Year
- EVGN $38.71
- APCX N/A
- P/E Ratio
- EVGN N/A
- APCX N/A
- Revenue Growth
- EVGN 30.69
- APCX N/A
- 52 Week Low
- EVGN $1.20
- APCX $0.31
- 52 Week High
- EVGN $10.40
- APCX $2.30
- Technical
- Relative Strength Index (RSI)
- EVGN 36.47
- APCX 60.21
- Support Level
- EVGN $1.20
- APCX $0.36
- Resistance Level
- EVGN $1.49
- APCX $1.49
- Average True Range (ATR)
- EVGN 0.12
- APCX 0.14
- MACD
- EVGN 0.01
- APCX 0.02
- Stochastic Oscillator
- EVGN 35.71
- APCX 24.32
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.